Literature DB >> 20055708

Epac: defining a new mechanism for cAMP action.

Martijn Gloerich1, Johannes L Bos.   

Abstract

cAMP is a second messenger that is essential for relaying hormonal responses in many biological processes. The discovery of the cAMP target Epac explained various effects of cAMP that could not be attributed to the established targets PKA and cyclic nucleotide-gated ion channels. Epac1 and Epac2 function as guanine nucleotide exchange factors for the small G protein Rap. cAMP analogs that selectively activate Epac have helped to reveal a role for Epac in processes ranging from insulin secretion to cardiac contraction and vascular permeability. Advances in the understanding of the activation mechanism of Epac and its regulation by diverse anchoring mechanisms have helped to elucidate the means by which cAMP fulfills these functions via Epac.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20055708     DOI: 10.1146/annurev.pharmtox.010909.105714

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  220 in total

1.  Induction of intracellular calcium concentration by environmental benzo(a)pyrene involves a β2-adrenergic receptor/adenylyl cyclase/Epac-1/inositol 1,4,5-trisphosphate pathway in endothelial cells.

Authors:  Abdullah Mayati; Nicolas Levoin; Hervé Paris; Monique N'Diaye; Arnaud Courtois; Philippe Uriac; Dominique Lagadic-Gossmann; Olivier Fardel; Eric Le Ferrec
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

Review 2.  Modulation of T cell immune functions by the prostaglandin E(2) - cAMP pathway in chronic inflammatory states.

Authors:  Kristoffer Watten Brudvik; Kjetil Taskén
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 3.  Regulation of the inflammatory response of vascular endothelial cells by EPAC1.

Authors:  Euan Parnell; Brian O Smith; Timothy M Palmer; Anna Terrin; Manuela Zaccolo; Stephen J Yarwood
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

4.  Suppression of Gαs synthesis by simvastatin treatment of vascular endothelial cells.

Authors:  Ruqin Kou; Takashi Shiroto; Juliano L Sartoretto; Thomas Michel
Journal:  J Biol Chem       Date:  2011-12-05       Impact factor: 5.157

Review 5.  Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.

Authors:  Thérèse Keravis; Claire Lugnier
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

6.  Optimized amplification and single-cell analysis identify GnRH-mediated activation of Rap1b in primary rat gonadotropes.

Authors:  Tony Yuen; Soon Gang Choi; Hanna Pincas; Dennis W Waring; Stuart C Sealfon; Judith L Turgeon
Journal:  Mol Cell Endocrinol       Date:  2011-11-25       Impact factor: 4.102

7.  Rap1GAP regulates renal cell carcinoma invasion.

Authors:  Wan-Ju Kim; Zachary Gersey; Yehia Daaka
Journal:  Cancer Lett       Date:  2012-01-20       Impact factor: 8.679

8.  cAMP regulates DEP domain-mediated binding of the guanine nucleotide exchange factor Epac1 to phosphatidic acid at the plasma membrane.

Authors:  Sarah V Consonni; Martijn Gloerich; Emma Spanjaard; Johannes L Bos
Journal:  Proc Natl Acad Sci U S A       Date:  2012-02-16       Impact factor: 11.205

9.  Profiling of Differential Expression of Genes in Mice Carrying Both Mutant Presenilin 1 and Amyloid Precursor Protein Transgenes with or without Knockout of B2 Adrenergic Receptor Gene.

Authors:  Yuan Zhou; Lintao Chen; Xi Zhou; Yechun Pei; Shuangshuang Wei; Anum Mehmood; Yang K Xiang; Dayong Wang
Journal:  J Appl Bioinforma Comput Biol       Date:  2018-09-18

10.  The PTH-Gαs-protein kinase A cascade controls αNAC localization to regulate bone mass.

Authors:  Martin Pellicelli; Julie A Miller; Alice Arabian; Claude Gauthier; Omar Akhouayri; Joy Y Wu; Henry M Kronenberg; René St-Arnaud
Journal:  Mol Cell Biol       Date:  2014-02-18       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.